AIM
TECH icon

Achmea Investment Management’s Bio-Techne TECH Stock Holding History

Achmea Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-468
Closed -$38K – 618
2023
Q2 		$38K Hold
468
– – ﹤0.01% 589
2023
Q1 		$35K Sell
468
-8,314
-95% -$641K ﹤0.01% 558
2022
Q4 		$682K Sell
8,782
-246
-3% -$19.5K 0.02% 449
2022
Q3 		$641K Hold
9,028
– – 0.02% 453
2022
Q2 		$782K Hold
9,028
– – 0.03% 440
2022
Q1 		$977K Hold
9,028
– – 0.03% 456
2021
Q4 		$1.17M Hold
9,028
– – 0.06% 234
2021
Q3 		$1.09M Buy
9,028
+468
+5% +$57K 0.03% 420
2021
Q2 		$964K Buy
+8,560
New +$901K 0.03% 421

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Achmea Investment Management's TECH Position: Q3 2023 in Review

Achmea Investment Management sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 468 shares — an estimated $38K sold.

Achmea Investment Management first reported a position in TECH in Q2 2021 and held it in 9 quarters. The position peaked at $1.17M in Q4 2021. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

  • Achmea Investment Management reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
  • Achmea Investment Management sold 468 Bio-Techne shares in Q3 2023, an estimated $38K.
  • Achmea Investment Management first reported a position in Bio-Techne in Q2 2021 and held it in 9 quarters.
  • Achmea Investment Management's Bio-Techne position peaked at $1.17M in Q4 2021.
  • 530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Achmea Investment Management's 13F filing for Q3 2023, filed 6 Nov 2023.